Implications for urgent transfusion of uncrossmatched blood in the emergency department: The prevalence of clinically significant red cell antibodies within different patient groups

Emergency Medicine

Volumn 15, Issue 3, 2003, Pages 239-243

  Saverimuttu, Josobel ^a,b   Greenfield, Tony ^c   Rotenko, Irene ^c   Crozier, John ^c   Jalaludin, Bin ^c   Harvey, Michael ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c NONE

Author keywords

Blood grouping and crossmatching; Emergency treatment; Multiple trauma

Indexed keywords

ALLOANTIBODY; ERYTHROCYTE ANTIBODY;

ADULT; AGE; ALLOIMMUNIZATION; BLOOD BANK; BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD GROUP RH; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HUMAN; MALE; MULTIPLE TRAUMA; PARITY; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SAFETY; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AUTOANTIBODIES; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; EMERGENCY MEDICAL SERVICES; ERYTHROCYTES; FEMALE; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0037592798     PISSN: 10356851     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2026.2003.00442.x     Document Type: Review

References (14)

1. Barnes AJ. Status of the use of universal donor blood transfusion. CRC Crit. Rev. Clin. Lab. Sci. 1973; 4: 147-60.
2. Crosby WH, Akeroyd JH. Some immuno-hematologic results of large transfusions of group O blood in recipients of other blood groups. Blood 1954; 9: 103-16.
3. Lefebre J, McLellan BA, Coovadia AS. Seven years experience with group O unmatched packed red blood cells in a regional trauma unit. Ann. Emerg. Med. 1987; 16: 1344-9.
4. Schwab CW, Shayne JP, Turner J. Immediate trauma resuscitation with type O uncrossmatched blood: a two-year prospective experience. J. Trauma 1986; 10: 897-902.
5. Gervin AS, Fisher RP. Resuscitation of trauma patients with type-specific uncrossmatched blood. J. Trauma 1984; 24: 327-9.
6. Schonewille H, Haak HL, van Zijl AM. Alloimmunisation after blood transfusion in patients with haematologic and oncologic diseases. Transfusion 1999; 39: 763-71.
7. American Association of Blood Banks. Technical Manual, 12th edn; Bethesda, Maryland, USA: American Association of Blood Banks, 1996.
8. Mollison PL, Engelfriet CP, Contreas M. Blood Transfusion in Clinical Medicine, 10th edn. Oxford: Blackwell, 1997.
9. Hoeltge GA, Domen RE, Rybicki LA, Schaffer PA. Multiple red cell transfusions and alloimmunisation. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch. Pathol. Lab. Med. 1995; 119: 42-5.
10. Heddle NM, Soutar RL, O'Hoski PL et al. A prospective study to determine the frequency and clinical significance of alloimmunisation post-transfusion. Br. J. Haematol. 1995; 91: 1000-5.
11. Lasky LC, Rose RR, Polesky HF. Incidence of antibody formation and positive direct antiglobulin tests in a mutitransfused hemodialysis population. Transfusion 1984; 24: 198-200.
12. Fluit CR, Kunst VA, Drenthe-Schonk AM. Incidence of red cell antibodies after multiple blood transfusions. Transfusion 1990; 30: 532-5.
13. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993; 81: 1109-23.
14. Harvey MP, Greenfield TP, Sugrue ME, Rosenfeld D. Massive blood transfusion in a tertiary referral hospital. Clinical outcomes and haemostatic complications. Med. J. Aust. 1995; 163: 356-9.